Clinical Trial Update: SHR-1811 Combined With Carboplatin in the Treatment of Advanced Breast Cancer With HER2 Expression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SHR-1811 in combination with carboplatin for advanced breast cancer expressing HER2; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• SHR-1811

Snippet

Sponsor: Anhui Provincial Cancer Hospital | Conditions: Breast Cancer | Phase 2 | Status: NOT_YET_RECRUITING